AK
Anil Kumar
Texas A&M Health Science Center, Thomas Jefferson University, National Centre For Cell Science
0000-0002-7611-5918
About
1. Ren Y, Kumar A, Das JK, et alTumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasionJournal for ImmunoTherapy of Cancer 2022;10:e004856. doi: 10.1136/jitc-2022-004856
https://www.ncbi.nlm.nih.gov/myncbi/anil.kumar.6/bibliography/public/
Employment
-
Texas A&M Health Science Center Postdoc2018 - Present
-
Thomas Jefferson University Postdoc2017 - 2017
Education
-
National Centre For Cell Science PhD2009 - 2015
Projects & Funding
Projects & funding information is unavailable.
Publications (29)
- eEF2K promotes immune evasion in melanoma via Cyclin D1–mediated stabilization of PD-L1 Save
- Metabolic Fitness of NAC1-Deficient Regulatory T Cells in the Tumor Microenvironment Fuels Tumor Growth Save
- Exploring the interplay of kinases and transcription factors in immunometabolism Save
- Targeting immunometabolism to improve cancer therapies Save
- NAC1 deficient regulatory T cell support tumor growth by CD36 mediated metabolic adaptation in tumor microenvironment. Save
- Control of CD4+ T cells to restrain inflammatory diseases via eukaryotic elongation factor 2 kinase Save
- NAC1 confines virus-specific memory formation of CD4+ T cells through the ROCK1-mediated pathway. Save
- T Cell Response to SARS-CoV-2 Coinfection and Comorbidities Save
- Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion. Save
- NAC1 modulates autoimmunity by suppressing regulatory T cell-mediated tolerance Save